Literature DB >> 27003569

[Urosepsis. Update on diagnosis and treatment].

F M E Wagenlehner1, J Alidjanov2, A Pilatz2.   

Abstract

BACKGROUND: Sepsis is an acute systemic response to the presence of bacteria and bacterial components in the macroorganism, and urosepsis is defined as sepsis caused by an infection in the urogenital tract. The urogenital tract is considered to be responsible for about 30 % of the cases of septic processes, whereby obstructive uropathy is causative in about 80 % of these cases. Sepsis manifests as an initially predominant proinflammatory response by widespread release of inflammatory mediators as a result of activation of cells responsive to infectious components such as bacterial toxins, which is then accompanied by a counter-regulatory anti-inflammatory response. DIAGNOSIS AND THERAPY: Prior to antibiotic therapy, blood and urine cultures are recommended, while procalcitonin and lactate can be considered diagnostically relevant biomarkers. Furthermore, early imaging to localize the level of obstruction and infectious focus should be carried out. Treatment is divided into causal therapy (antimicrobial therapy and infectious source), supportive therapy (fluids and oxygen administration), and adjunctive therapy (sepsis-specific therapy).

Entities:  

Keywords:  Anti-bacterial agents; Obstructive uropathy; Systemic inflammatory response syndrome; Urinary tract infection; Urogenital system

Mesh:

Substances:

Year:  2016        PMID: 27003569     DOI: 10.1007/s00120-016-0066-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  14 in total

Review 1.  The pathophysiology and treatment of sepsis.

Authors:  Richard S Hotchkiss; Irene E Karl
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 3.  Urosepsis: Overview of the Diagnostic and Treatment Challenges.

Authors:  Florian M E Wagenlehner; Adrian Pilatz; Wolfgang Weidner; Kurt G Naber
Journal:  Microbiol Spectr       Date:  2015-10

Review 4.  Urosepsis--Etiology, Diagnosis, and Treatment.

Authors:  Nici Markus Dreger; Stephan Degener; Parviz Ahmad-Nejad; Gabriele Wöbker; Stephan Roth
Journal:  Dtsch Arztebl Int       Date:  2015-12-04       Impact factor: 5.594

5.  How do we manage infected, obstructed hydronephrosis?

Authors:  Brian R Matlaga
Journal:  Eur Urol       Date:  2012-10-16       Impact factor: 20.096

6.  Renal function during acute total ureteral occlusion and the role of the lymphatics: an experimental study in dogs.

Authors:  K G Naber; P O Madsen
Journal:  J Urol       Date:  1973-03       Impact factor: 7.450

7.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

8.  [Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)].

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Anaesthesist       Date:  2010-04       Impact factor: 1.041

9.  Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis.

Authors:  Georg F Weber; Benjamin G Chousterman; Shun He; Ashley M Fenn; Manfred Nairz; Atsushi Anzai; Thorsten Brenner; Florian Uhle; Yoshiko Iwamoto; Clinton S Robbins; Lorette Noiret; Sarah L Maier; Tina Zönnchen; Nuh N Rahbari; Sebastian Schölch; Anne Klotzsche-von Ameln; Triantafyllos Chavakis; Jürgen Weitz; Stefan Hofer; Markus A Weigand; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

10.  Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013.

Authors:  Zafer Tandoğdu; Ricardo Bartoletti; Tomasso Cai; Mete Çek; Magnus Grabe; Ekaterina Kulchavenya; Bela Köves; Vandana Menon; Kurt Naber; Tamara Perepanova; Peter Tenke; Björn Wullt; Truls Erik Bjerklund Johansen; Florian Wagenlehner
Journal:  World J Urol       Date:  2015-12-11       Impact factor: 4.226

View more
  1 in total

1.  Differential protein expression in patients with urosepsis.

Authors:  Xu-Kai Yang; Nan Wang; Cheng Yang; Yang-Min Wang; Tuan-Jie Che
Journal:  Chin J Traumatol       Date:  2018-10-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.